Current Drug Targets - CNS & Neurological Disorders
Continued as: CNS & Neurological Disorders - Drug Targets
Volume , Issues,
ISSN: 1568-007X (Online)
ISSN: 1568-007X (Print)
This journal supports open access
ISSN: 1568-007X (Online)
ISSN: 1568-007X (Print)
This journal supports open access
Contents
Current Drug Targets - CNS & Neurological Disorders , Volume 2 - Number 3
Recent Knowledge on Molecular Components of Lewy Bodies Discloses Future Therapeutic Strategies in Parkinsons Disease
, 2(3): 149 - 152F. Fornai, P. Lenzi, M. Gesi, M. Ferrucci, G. Lazzeri, G. Natale, S. Ruggieri and A. Paparelli
DOI: 10.2174/1568007033482904
FK506 and Its Analogs - Therapeutic Potential for Neurological Disorders
, 2(3): 153 - 162Alexa Klettner and Thomas Herdegen
DOI: 10.2174/1568007033482878
Role of Acetylcholinesterase Inhibitors in the Metabolism of Amyloid Precursor Protein
, 2(3): 163 - 171M. Pakaski and P. Kasa
DOI: 10.2174/1568007033482869
Calpain and Its Involvement in the Pathophysiology of CNS Injuries and Diseases: Therapeutic Potential of Calpain Inhibitors for Prevention of Neurodegeneration
, 2(3): 173 - 189Swapan K. Ray and Naren L. Banik
DOI: 10.2174/1568007033482887
The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders
, 2(3): 191 - 200Guy Griebel, Jacques Simiand, Jeanne Stemmelin, Claudine Serradeil-Le Gal and Regis Steinberg
DOI: 10.2174/1568007033482850
CART Peptides as Targets for CNS Drug Development
, 2(3): 201 - 205Richard G. Hunter and Michael J. Kuhar
DOI: 10.2174/1568007033482896
Webmaster Contact: info@benthamscience.net